An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade
Shuguang Zuo(Nanjing University), Jiwu Wei(China Pharmaceutical University), Junhua Wu(South China Agricultural University), Tiancheng Xu(Nanjing University of Chinese Medicine), Bohao He(China Pharmaceutical University), Jie Dong(University of Science and Technology of China), Min Wei(Nanjing Agricultural University), Shibing Wang(Hangzhou Medical College), Lingkai Kong(Nanjing University), Shiqun Wang(Hangzhou Cancer Hospital)
Cited by 75
Related Papers
TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response
|PLoS Genetics|2019|287
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma
|Frontiers in Immunology|2020|260
Epichlorohydrin-Cross-linked Hydroxyethyl Cellulose/Soy Protein Isolate Composite Films as Biocompatible and Biodegradable Implants for Tissue Engineering
|ACS Applied Materials & Interfaces|2016|149